{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:52:09Z","timestamp":1791183129802,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbamem.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T02:46:13Z","timestamp":1429152373000},"page":"2665-2676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"PB","title":["Autoimmune channelopathies in paraneoplastic neurological syndromes"],"prefix":"10.1016","volume":"1848","author":[{"given":"Bastien","family":"Joubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bbamem.2015.04.003_bb0005","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"16","key":"10.1016\/j.bbamem.2015.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bbamem.2015.04.003_bb0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neurol.2014.07.007","article-title":"Therapeutic approaches in antibody-associated central nervous system pathologies","volume":"170","author":"Honnorat","year":"2014","journal-title":"Rev. Neurol. (Paris)"},{"issue":"8","key":"10.1016\/j.bbamem.2015.04.003_bb0020","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.bbamem.2015.04.003_bb0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0040","unstructured":"Eric R. Kandel, Thomas M. Jessell, James H. Schwartz. Principles of Neural Science."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fncel.2014.00160","article-title":"The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse","volume":"8","author":"Fan","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2012.06.029","article-title":"Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists","volume":"150","author":"Papouin","year":"2012","journal-title":"Cell"},{"issue":"27","key":"10.1016\/j.bbamem.2015.04.003_bb0055","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1523\/JNEUROSCI.1380-04.2004","article-title":"Fast and slow voltage-dependent dynamics of magnesium block in the NMDA receptor: the asymmetric trapping block model","volume":"24","author":"Vargas-Caballero","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"7","key":"10.1016\/j.bbamem.2015.04.003_bb0060","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0092-8674(00)81827-9","article-title":"The Essential Role of Hippocampal CA1 NMDA Receptor\u2013Dependent Synaptic Plasticity in Spatial Memory","volume":"87","author":"Tsien","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-3223(99)00097-9","article-title":"Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions","volume":"47","author":"Krystal","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbamem.2015.04.003_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","article-title":"Excitotoxicity and stroke: identifying novel targets for neuroprotection","volume":"115","author":"Lai","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fncel.2013.00031","article-title":"NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia","volume":"7","author":"Snyder","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","article-title":"NMDA receptor subunits: diversity, development and disease","volume":"11","author":"Cull-Candy","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.bbamem.2015.04.003_bb0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.bbamem.2015.04.003_bb0095","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.bbamem.2015.04.003_bb0100","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","article-title":"Late-onset anti-NMDA receptor encephalitis","volume":"81","author":"Titulaer","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti\u2013N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.bbamem.2015.04.003_bb0110","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0000000000000126","article-title":"Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis","volume":"82","author":"Viaccoz","year":"2014","journal-title":"Neurology"},{"issue":"Pt 6","key":"10.1016\/j.bbamem.2015.04.003_bb0115","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain J. Neurol."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","article-title":"Cognitive deficits following anti-NMDA receptor encephalitis","volume":"83","author":"Finke","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1-2","key":"10.1016\/j.bbamem.2015.04.003_bb0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jneuroim.2013.09.017","article-title":"Rituximab ameliorates anti-N-methyl-D-aspartate receptor encephalitis by removal of short-lived plasmablasts","volume":"265","author":"Hachiya","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.bbamem.2015.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2169\/internalmedicine.51.6874","article-title":"Rituximab used successfully in the treatment of anti-NMDA receptor encephalitis","volume":"51","author":"Ikeguchi","year":"2012","journal-title":"Intern. Med."},{"issue":"12","key":"10.1016\/j.bbamem.2015.04.003_bb0135","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"32","key":"10.1016\/j.bbamem.2015.04.003_bb0140","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1523\/JNEUROSCI.0064-12.2012","article-title":"Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain","volume":"32","author":"Gleichman","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"8","key":"10.1016\/j.bbamem.2015.04.003_bb0145","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/embj.201386356","article-title":"Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses","volume":"33","author":"Dupuis","year":"2014","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis","volume":"76","author":"Moscato","year":"2014","journal-title":"Ann. Neurol."},{"issue":"17","key":"10.1016\/j.bbamem.2015.04.003_bb0155","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"Pt 5","key":"10.1016\/j.bbamem.2015.04.003_bb0160","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain J. Neurol."},{"issue":"Pt 1","key":"10.1016\/j.bbamem.2015.04.003_bb0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planagum\u00e0","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-5-31","article-title":"In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction","volume":"5","author":"Manto","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00415-010-5674-5","article-title":"Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies","volume":"258","author":"Manto","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2202-14-17","article-title":"In vitro neuronal network activity in NMDA receptor encephalitis","volume":"14","author":"Jantzen","year":"2013","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0185","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nbd.2011.09.019","article-title":"Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients","volume":"45","author":"Zhang","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0200","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1468-1331.2010.03180.x","article-title":"Brain immunohistopathological study in a patient with anti-NMDAR encephalitis","volume":"18","author":"Camdessanch\u00e9","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0205","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Potential Biomarker of Treatment Response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/dmcn.12036","article-title":"Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis","volume":"55","author":"Dale","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Diagnosis and significance of antibody titers in anti-NMDA receptor encephalitis, a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1-2","key":"10.1016\/j.bbamem.2015.04.003_bb0220","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000353982","article-title":"Immunopathological significance of ovarian teratoma in patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"71","author":"Tabata","year":"2014","journal-title":"Eur. Neurol."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0225","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamaneurol.2014.488","article-title":"Abnormal neurons in teratomas in NMDAR encephalitis","volume":"71","author":"Day","year":"2014","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PGP.0b013e31824a1de2","article-title":"Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates","volume":"31","author":"Dabner","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1620\/tjem.230.13","article-title":"Identification of the N-Methyl-D-aspartate receptor (NMDAR)-related epitope, NR2B, in the normal human ovary: implication for the pathogenesis of anti-NMDAR encephalitis","volume":"230","author":"Tachibana","year":"2013","journal-title":"Tohoku J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0240","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2013.15.1\/jhenley","article-title":"AMPA receptor trafficking and the mechanisms underlying synaptic plasticity and cognitive aging","volume":"15","author":"Henley","year":"2013","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0250","article-title":"Assembly of AMPA receptors: mechanisms and regulation","volume":"11","author":"Gan","year":"2014","journal-title":"J. Physiol."},{"issue":"10","key":"10.1016\/j.bbamem.2015.04.003_bb0255","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The expanding clinical profile of anti-AMPA receptor encephalitis","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.bbamem.2015.04.003_bb0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jneuroim.2013.05.011","article-title":"Rapid progression and brain atrophy in anti-AMPA receptor encephalitis","volume":"261","author":"Wei","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.0b013e3181cb3e52","article-title":"Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor","volume":"74","author":"Bataller","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0270","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/acn3.43","article-title":"Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis","volume":"1","author":"Gleichman","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0275","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nn1678","article-title":"Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation","volume":"9","author":"Plant","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"26","key":"10.1016\/j.bbamem.2015.04.003_bb0280","doi-asserted-by":"crossref","first-page":"11999","DOI":"10.1073\/pnas.0913004107","article-title":"Perisynaptic GluR2-lacking AMPA receptors control the reversibility of synaptic and spines modifications","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fncel.2013.00113","article-title":"The possible role of GABAA receptors and gephyrin in epileptogenesis","volume":"7","author":"Gonz\u00e1lez","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0290","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/neuro.02.007.2008","article-title":"GABA(A) Receptor Dynamics and Constructing GABAergic Synapses","volume":"1","author":"Tretter","year":"2008","journal-title":"Front. Mol. Neurosci."},{"issue":"29","key":"10.1016\/j.bbamem.2015.04.003_bb0300","doi-asserted-by":"crossref","first-page":"21458","DOI":"10.1074\/jbc.M112.444372","article-title":"Altered cortical GABAA receptor composition, physiology, and endocytosis in a mouse model of a human genetic absence epilepsy syndrome","volume":"288","author":"Zhou","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.bbamem.2015.04.003_bb0305","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","article-title":"Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis","volume":"34","author":"Ohkawa","year":"2014","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0310","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0315","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropharm.2008.06.063","article-title":"A nomenclature for ligand-gated ion channels","volume":"56","author":"Collingridge","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbamem.2015.04.003_bb0320","article-title":"The nicotinic acetylcholine receptor and its prokaryotic homologues: Structure, conformational transitions & allosteric modulation","author":"Cecchini","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0325","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02740634","article-title":"Nicotinic acetylcholine receptors in health and disease","volume":"15","author":"Lindstrom","year":"1997","journal-title":"Mol. Neurobiol."},{"issue":"24","key":"10.1016\/j.bbamem.2015.04.003_bb0335","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.4103\/1673-5374.147943","article-title":"Activities of nicotinic acetylcholine receptors modulate neurotransmission and synaptic architecture","volume":"9","author":"Oda","year":"2014","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.bbamem.2015.04.003_bb0340","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O","article-title":"Acetylcholine receptors and myasthenia","volume":"23","author":"Lindstrom","year":"2000","journal-title":"Muscle Nerve"},{"issue":"7930","key":"10.1016\/j.bbamem.2015.04.003_bb0345","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(75)92779-8","article-title":"Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis","volume":"2","author":"Aharonov","year":"1975","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0350","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.bbamem.2015.04.003_bb0355","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0360","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0365","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor\u2013related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann. Neurol."},{"issue":"4088","key":"10.1016\/j.bbamem.2015.04.003_bb0370","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.bbamem.2015.04.003_bb0375","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1196\/annals.1405.037","article-title":"Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?","volume":"1132","author":"Soltys","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.bbamem.2015.04.003_bb0380","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.4049\/jimmunol.138.10.3269","article-title":"Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane","volume":"138","author":"Corey","year":"1987","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.bbamem.2015.04.003_bb0385","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.80.13.4089","article-title":"Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia","volume":"80","author":"Gomez","year":"1983","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4273","key":"10.1016\/j.bbamem.2015.04.003_bb0390","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.831257","article-title":"Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis","volume":"195","author":"Kao","year":"1977","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0395","first-page":"82","article-title":"Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3","volume":"67","author":"R\u00f8dgaard","year":"1987","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0400","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0405","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The Role of the Thymus in Myasthenia Gravis: Immunohistological and Immunological Studies in 115 Casesa","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.bbamem.2015.04.003_bb0410","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/JTO.0000000000000269","article-title":"Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors","volume":"9","author":"Huang","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"5-6","key":"10.1016\/j.bbamem.2015.04.003_bb0415","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/08916930903555935","article-title":"Thymoma and paraneoplastic myasthenia gravis","volume":"43","author":"Marx","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bbamem.2015.04.003_bb0420","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-cellbio-092910-154008","article-title":"Mechanisms of T cell development and transformation","volume":"27","author":"Koch","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0425","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","article-title":"Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)","volume":"211","author":"Str\u00f6bel","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0430","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1196\/annals.1405.018","article-title":"Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms","volume":"1132","author":"Str\u00f6bel","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0435","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/cimm.1995.1025","article-title":"Accumulation of immature CD3-CD4+CD8- single-positive cells that lack CD69 in epithelial cell tumors of the human thymus","volume":"161","author":"Takeuchi","year":"1995","journal-title":"Cell. Immunol."},{"issue":"8","key":"10.1016\/j.bbamem.2015.04.003_bb0440","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/08916930903120941","article-title":"Regulation of Th-POK and Runx3 in T cell development in human thymoma","volume":"42","author":"Tokunaga","year":"2009","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0445","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.1017","article-title":"Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0450","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.20340","article-title":"Selective loss of regulatory T cells in thymomas","volume":"56","author":"Str\u00f6bel","year":"2004","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0455","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/eji.201041253","article-title":"Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications","volume":"41","author":"Kisand","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0460","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.10556","article-title":"The spectrum of autoimmune autonomic neuropathies","volume":"53","author":"Klein","year":"2003","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0465","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archneurol.2009.78","article-title":"Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments","volume":"66","author":"McKeon","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0470","article-title":"Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center","author":"Li","year":"2014","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.bbamem.2015.04.003_bb0475","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0480","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI17429","article-title":"Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease","volume":"111","author":"Lennon","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"32","key":"10.1016\/j.bbamem.2015.04.003_bb0485","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1523\/JNEUROSCI.1485-04.2004","article-title":"Passive transfer of autoimmune autonomic neuropathy to mice","volume":"24","author":"Vernino","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0490","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2009.12.016","article-title":"Antibody-mediated impairment and homeostatic plasticity of autonomic ganglionic synaptic transmission","volume":"222","author":"Wang","year":"2010","journal-title":"Exp. Neurol."},{"issue":"22","key":"10.1016\/j.bbamem.2015.04.003_bb0495","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1212\/01.wnl.0000263185.30294.61","article-title":"Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current","volume":"68","author":"Wang","year":"2007","journal-title":"Neurology"},{"issue":"5-6","key":"10.1016\/j.bbamem.2015.04.003_bb0500","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/PL00000899","article-title":"The glycinergic inhibitory synapse","volume":"58","author":"Legendre","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"issue":"48","key":"10.1016\/j.bbamem.2015.04.003_bb0505","doi-asserted-by":"crossref","first-page":"40216","DOI":"10.1074\/jbc.R112.408229","article-title":"Inhibitory glycine receptors: an update","volume":"287","author":"Dutertre","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bbamem.2015.04.003_bb0510","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0515","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/WNL.0b013e318227b176","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies","volume":"77","author":"Turner","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0520","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","article-title":"Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype","volume":"70","author":"McKeon","year":"2013","journal-title":"JAMA Neurol."},{"issue":"Pt 8","key":"10.1016\/j.bbamem.2015.04.003_bb0525","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain J. Neurol."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0530","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.10279","article-title":"Stiff man syndrome and related conditions","volume":"17","author":"Meinck","year":"2002","journal-title":"Mov. Disord."},{"issue":"Pt 4","key":"10.1016\/j.bbamem.2015.04.003_bb0535","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/brain\/114.4.1903","article-title":"The hyperekplexias and their relationship to the normal startle reflex","volume":"114","author":"Brown","year":"1991","journal-title":"Brain J. Neurol."},{"issue":"11","key":"10.1016\/j.bbamem.2015.04.003_bb0540","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/brain\/awq253","article-title":"Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition","volume":"133","author":"Geis","year":"2010","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(92)90504-3","article-title":"Glycine-like immunoreactive input to sympathetic preganglionic neurons","volume":"571","author":"Cabot","year":"1992","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0550","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0306-4522(96)00278-3","article-title":"Distribution of glycine-immunoreactive cell bodies and fibers in the rat brain","volume":"75","author":"Rampon","year":"1996","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0555","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cne.22212","article-title":"Differential localization of gamma-aminobutyric acid type A and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: an immunohistochemical study","volume":"518","author":"Waldvogel","year":"2010","journal-title":"J. Comp. Neurol."},{"issue":"Pt 2","key":"10.1016\/j.bbamem.2015.04.003_bb0560","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1113\/jphysiol.1995.sp020682","article-title":"Role of fast inhibitory synaptic mechanisms in respiratory rhythm generation in the maturing mouse","volume":"484","author":"Paton","year":"1995","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0565","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/cphy.c110047","article-title":"K(+) channels: function-structural overview","volume":"2","author":"Gonz\u00e1lez","year":"2012","journal-title":"Comp. Physiol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cbdd.12237","article-title":"Potassium Channels: Structures, Diseases, and Modulators","volume":"83","author":"Tian","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.bbamem.2015.04.003_bb0575","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1021\/bi00173a001","article-title":"Antibodies specific for distinct Kv subunits unveil a heterooligomeric basis for subtypes of alpha-dendrotoxin-sensitive K+ channels in bovine brain","volume":"33","author":"Scott","year":"1994","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bbamem.2015.04.003_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2013.00196","article-title":"Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases","volume":"7","author":"Faivre-Sarrailh","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.bbamem.2015.04.003_bb0585","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.clinph.2006.03.008","article-title":"Neuromyotonia","volume":"117","author":"Maddison","year":"2006","journal-title":"Clin. Neurophysiol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbamem.2015.04.003_bb0590","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1167.2012.03484.x","article-title":"Kv1.1 and Kv1.2: similar channels, different seizure models","volume":"53","author":"Robbins","year":"2012","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0595","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0600","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jnnp.65.6.857","article-title":"Morvan\u2019s fibrillary chorea: a paraneoplastic manifestation of thymoma","volume":"65","author":"Lee","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.bbamem.2015.04.003_bb0610","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain J. Neurol."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0615","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.bbamem.2015.04.003_bb0620","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"issue":"46","key":"10.1016\/j.bbamem.2015.04.003_bb0625","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to Epilepsy-Related LGI1 in Limbic Encephalitis Neutralize LGI1-ADAM22 Interaction and Reduce Synaptic AMPA Receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0630","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol."},{"issue":"22","key":"10.1016\/j.bbamem.2015.04.003_bb0635","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1038\/sj.onc.1202481","article-title":"A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors","volume":"17","author":"Chernova","year":"1998","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bbamem.2015.04.003_bb0640","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1073\/pnas.0914537107","article-title":"Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy","volume":"107","author":"Fukata","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0645","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2006.01.033","article-title":"The Epilepsy-Linked Lgi1 Protein Assembles into Presynaptic Kv1 Channels and Inhibits Inactivation by Kv\u03b21","volume":"49","author":"Schulte","year":"2006","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0650","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0595-56","article-title":"Localization of a gene for partial epilepsy to chromosome 10q","volume":"10","author":"Ottman","year":"1995","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.bbamem.2015.04.003_bb0655","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00415-014-7408-6","article-title":"Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity","volume":"261","author":"Malter","year":"2014","journal-title":"J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.bbamem.2015.04.003_bb0660","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: Clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0665","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0670","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2014.1234","article-title":"EPisodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex\/leucine-rich, glioma inactivated 1 antibody encephalitis","author":"Naasan","year":"2014","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.bbamem.2015.04.003_bb0675","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/jnnp.2009.178293","article-title":"An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis","volume":"81","author":"Wong","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0680","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/jnnp-2013-305218","article-title":"Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre","volume":"85","author":"Paterson","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 5","key":"10.1016\/j.bbamem.2015.04.003_bb0685","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain J. Neurol."},{"issue":"9","key":"10.1016\/j.bbamem.2015.04.003_bb0690","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.febslet.2009.08.025","article-title":"GPI-anchored proteins at the node of Ranvier","volume":"584","author":"Labasque","year":"2010","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.bbamem.2015.04.003_bb0695","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1083\/jcb.200305018","article-title":"Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1","volume":"162","author":"Poliak","year":"2003","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0700","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ajhg.2009.10.004","article-title":"CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila","volume":"85","author":"Zweier","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"44","key":"10.1016\/j.bbamem.2015.04.003_bb0705","doi-asserted-by":"crossref","first-page":"18120","DOI":"10.1073\/pnas.1216398109","article-title":"Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development","volume":"109","author":"Anderson","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0710","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann. Neurol."},{"issue":"17","key":"10.1016\/j.bbamem.2015.04.003_bb0715","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies","volume":"82","author":"Balint","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0720","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.mcn.2005.02.003","article-title":"Transmembrane interaction mediates complex formation between peptidase homologues and Kv4 channels","volume":"29","author":"Ren","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"issue":"19","key":"10.1016\/j.bbamem.2015.04.003_bb0725","doi-asserted-by":"crossref","first-page":"18853","DOI":"10.1074\/jbc.M410613200","article-title":"DPP10 Modulates Kv4-mediated A-type Potassium Channels","volume":"280","author":"Zagha","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.04.003_bb0730","doi-asserted-by":"crossref","DOI":"10.3389\/neuro.02.008.2008","article-title":"DPP6 localization in brain supports function as a Kv4 channel associated protein","volume":"1","author":"Clark","year":"2008","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0735","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","article-title":"Neuronal voltage-gated calcium channels: structure, function, and dysfunction","volume":"82","author":"Simms","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0740","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2169\/internalmedicine.38.86","article-title":"An autoimmune channelopathy associated with cancer: Lambert-Eaton myasthenic syndrome","volume":"38","author":"Takamori","year":"1999","journal-title":"Intern. Med."},{"issue":"12","key":"10.1016\/j.bbamem.2015.04.003_bb0745","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.clinph.2014.06.031","article-title":"Lambert-Eaton myasthenic syndrome - Diagnosis, pathogenesis and therapy","volume":"125","author":"H\u00fclsbrink","year":"2014","journal-title":"Clin. Neurophysiol."},{"issue":"7","key":"10.1016\/j.bbamem.2015.04.003_bb0750","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","article-title":"Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS","volume":"29","author":"Titulaer","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.bbamem.2015.04.003_bb0755","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0760","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0765","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/WNL.48.5.1261","article-title":"Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome","volume":"48","author":"Takamori","year":"1997","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.bbamem.2015.04.003_bb0770","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0166-2236(89)90109-4","article-title":"Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder","volume":"12","author":"Vincent","year":"1989","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.bbamem.2015.04.003_bb0780","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.410400510","article-title":"Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma","volume":"40","author":"Meriney","year":"1996","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.bbamem.2015.04.003_bb0785","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0303-8467(02)00054-9","article-title":"Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases","volume":"104","author":"Wirtz","year":"2002","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1-2","key":"10.1016\/j.bbamem.2015.04.003_bb0790","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jneuroim.2004.10.018","article-title":"HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome","volume":"159","author":"Wirtz","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0795","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","article-title":"An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes","volume":"253","author":"Shams\u2019ili","year":"2006","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.bbamem.2015.04.003_bb0800","doi-asserted-by":"crossref","first-page":"e60438","DOI":"10.1371\/journal.pone.0060438","article-title":"Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer","volume":"8","author":"Sabater","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0805","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00415-009-5262-8","article-title":"Antineuronal antibodies in sporadic late-onset cerebellar ataxia","volume":"257","author":"B\u00fcrk","year":"2010","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0810","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.10392","article-title":"Reduction of P\/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome","volume":"53","author":"Fukuda","year":"2003","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.bbamem.2015.04.003_bb0815","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/mus.21315","article-title":"Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction","volume":"40","author":"Pellkofer","year":"2009","journal-title":"Muscle Nerve"},{"issue":"1-2","key":"10.1016\/j.bbamem.2015.04.003_bb0820","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jns.2013.10.031","article-title":"Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment","volume":"336","author":"Rigamonti","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"16","key":"10.1016\/j.bbamem.2015.04.003_bb0825","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1073\/pnas.88.16.7076","article-title":"Localization of P-type calcium channels in the central nervous system","volume":"88","author":"Hillman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbamem.2015.04.003_bb0830","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ana.10497","article-title":"Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?","volume":"53","author":"Fletcher","year":"2003","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.bbamem.2015.04.003_bb0835","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2013.05.003","article-title":"Intrathecal injection of P\/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice","volume":"261","author":"Mart\u00edn-Garc\u00eda","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"10.1016\/j.bbamem.2015.04.003_bb0840","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1073\/pnas.95.14.8328","article-title":"Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons","volume":"95","author":"Pinto","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bbamem.2015.04.003_bb0845","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1073\/pnas.0710771105","article-title":"Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo","volume":"105","author":"Liao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000527361500125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000527361500125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T13:57:09Z","timestamp":1691589429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000527361500125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":168,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S000527361500125X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2015.04.003","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune channelopathies in paraneoplastic neurological syndromes","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Biomembranes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamem.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}